Clinical implementation of a procedure to prepare bone marrow cells from cadaveric vertebral bodies

Regenerative Medicine

Volumn 6, Issue 6, 2011, Pages 701-706

  Donnenberg, Albert D ^a,b   Gorantla, Vijay S ^b,c   Schneeberger, Stefan ^d,e   Moore, Linda R ^a   Brandacher, Gerald ^d   Stanczak, Heather M ^a   Koch, Eileen K ^a   Lee, Wp Andrew ^d  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b MCGOWAN INSTITUTE FOR REGENERATIVE MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

composite organ transplantation; good manufacturing practices; hand transplantation; Pittsburgh Protocol; vertebral bodies; vertebral bone marrow

Indexed keywords

ARTICLE; BONE MARROW CELL; CADAVER; CELL ISOLATION; CELL SEPARATION; CELL VIABILITY; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; GOOD MANUFACTURING PRACTICE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PRIORITY JOURNAL; VERTEBRA BODY;

ADOLESCENT; ADULT; BONE MARROW CELLS; CADAVER; CELL CULTURE TECHNIQUES; CELL SURVIVAL; CRYOPRESERVATION; DEMOGRAPHY; HUMANS; MIDDLE AGED; SPINE; TIME FACTORS; TISSUE DONORS; YOUNG ADULT;

EID: 82955186998     PISSN: 17460751     EISSN: 1746076X     Source Type: Journal    
DOI: 10.2217/rme.11.89     Document Type: Article

References (17)

1. Fontes P, Rao AS, Carroll P et al. Bone marrow augmentation of donor-cell chimerism in kidney, liver, heart, and pancreas islet transplantation. Lancet 344, 151-155 (1994) (Pubitemid 24218877)
2. Rao AS, Fontes P, Zeevi A et al. Combined bone marrow and whole organ transplantation from the same donor. Transplant. Proc. 26, 3377-3378 (1994)
3. Pham SM, Keenan RJ, Rao AS et al. Perioperative donor bone marrow infusion augments chimerism in heart and lung transplant recipients. Ann. Thorac. Surg. 60, 1015-1020 (1995)
4. Rao AS, Phil D, Fontes P et al. An attempt to induce tolerance with infusion of donor bone marrow in organ allograft recipients. Adv. Exp. Med. Biol. 417, 269-274 (1997) (Pubitemid 27427754)
5. Millan MT, Shizuru JA, Hoffmann P et al. Mixed chimerism and immunosuppressive drug withdrawal after HLA-mismatched kidney and hematopoietic progenitor transplantation. Transplantation 73, 1386-1391 (2002) (Pubitemid 34547457)
6. Azari KK, Imbriglia JE, Goitz RJ et al. Technical aspects of the recipient operation in hand transplantation. J. Reconstr. Microsurg. doi: 10.1055/s-0031-1285820 (2011) (Epub ahead of print)
7. Gorantla VS, Schneeberger S, Moore LR et al. Development and validation of a procedure to isolate viable bone marrow cells from the vertebrae of cadaveric organ donors for composite organ grafting. Cytotherapy DOI: 10.3109/14653249.2011.605350 (2011) (Epub ahead of print)
8. Clinical and Laboratory Standards Institute.Laboratory Documents: Development and Control; Approved Guideline (Fifth Edition). Clinical and Laboratory Standards Institute, Wayne, PA, USA, 1-81 (2006)
9. Sutherland DR, Anderson L, Keeney M, Nayar R, Chin-Yee I. The ISHAGE guidelines for CD34+ cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering. J. Hematother. 5, 213-226 (1996)
10. Donnenberg AD, Koch EK, Griffin DL et al. Viability of cryopreserved BM progenitor cells stored for more than a decade. Cytotherapy 4, 157-163 (2002) (Pubitemid 34537335)
11. Mather JP, Roberts PE. Acridine orange-ethidium bromide viability determination. In: Introduction to Cell and Tissue Culture: Theory and Technique. Plenum Press, New York, NY, USA, 74 (1998)
12. Donnenberg AD. T-cell depletion and allograft engineering. In:Hematopoietic Stem Cell Therapy. Ball ED, Lister J, Law P (Eds). Churchill Livingstone, Philadelphia, PA, USA 335-344 (2000)
13. Sahota A, Gao S, Hayes J, Jindal RM. Microchimerism and rejection: A meta-analysis. Clin. Transplant. 14, 345-350 (2000) (Pubitemid 30497139)
14. Sharp TG, Sachs DH, Matthews JG, Maples J, Woody JN, Rosenberg SA. Harvest of human bone marrow directly from bone. J. Immunol. Methods 69, 187-195 (1984) (Pubitemid 14135674)
15. Rybka WB, Fontes PA, Rao AS et al. Hematopoietic progenitor cell content of vertebral body marrow used for combined solid organ and bone marrow transplantation. Transplantation 59, 871-874 (1995)
16. Moore S. Pancreatic DNase. In:The Enzymes (Volume 14). Boyer PD (Ed.). Academic Press, NY, USA, 281-296 (1981)
17. Windrum P, Morris TCM, Drake MB, Niederwieser D, Ruutu T. Variation in dimethyl sulfoxide use in stem cell transplantation: A survey of EBMT centres. Bone Marrow Transplant. 36, 601-603 (2005). (Pubitemid 43115015)